Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers.
Current customers who pay for the drugs out of pocket — without the help of health insurance — will now be charged $349 per month, down from $499, the Danish drugmaker said Monday.
Novo Nordisk also announced that it will charge $199 per month for new patients who pay for the drugs out of pocket, with the offer covering two months of the treatments. After that, the cost of the drugs will rise to $349 per month. The introductory $199 offer will be available through March 31, 2026, it said.
The new pricing for people who pay out of pocket for the two popular drugs comes amid a push from the Trump administration to lower their prices. In a deal announced earlier this month, the administration said people who rely on Medicare, Medicaid and the planned "TrumpRx" pharmaceutical website will get lower pricing for Novo Nordisk's GLP-1 drugs, as well as Eli Lilly's Zepbound.
At the time, administration officials said the drugs would cost an average of $245 to $350, a more accessible price point given they can retail for more than $1,000 per month.
Dave Moore, executive vice president of U.S. operations of Novo Nordisk, told CBS News in a statement that the company's new offer is intended to expand access to medicines for patients living with chronic diseases.
"Novo Nordisk is making it easier and more affordable for patients to access real FDA-approved treatments," he said.
Customers can get prescriptions at the new prices at wegovy.com or ozempic.com, at NovoCare Pharmacy or through other select providers such as Costco.
When the employed are pushed into homelessness
President Trump's pardon of crypto billionaire sparks concerns over his use of pardons
LATEST POSTS
- 1
Share your pick for the miniature headphones that you generally suggest! - 2EU delegation urges China to tighten export controls
- 3Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- 4Several injured as man threatens attack on German high-speed train
- 5'We were genuinely astonished': This moss survived 9 months outside the International Space Station and could still grow on Earth
- Pick Your Number one sort of blossom
- German mid-sized firms gloomy on outlook, survey finds
- Select Your Definitive Pizza Decision
- FDA updates risk classification for voluntary shredded cheese recall
- Activists: Venezuela released just nine prisoners despite promise
- UB professor shares his experience on almost becoming an astronaut
- I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
- Instructions to Keep up with Your Traded Teeth for Life span
- Defence chiefs of Thailand and Cambodia to discuss ceasefire
